TrialPanorama/TrialPanorama-database huggingface dataset:
Study 12900381 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 1880221 — Surrogate Endpoint (SUR): Blood pressure
Study 6605127 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22818725 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22818725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20118174 — Surrogate Endpoint (SUR): Blood pressure
Study 12583464 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 8478821 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18947029 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18947029 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 18947029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18947029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26119654 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16700996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16700996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11250719 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 22288685 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 18478944 — Surrogate Endpoint (SUR): Blood pressure
Study 415321 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25766513 — Surrogate Endpoint (SUR): Blood pressure
Study 23466100 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16766776 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 8222534 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 17673609 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 17673609 — Predictive Biomarker (PRD): Hormone receptor
Study 11966926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11966926 — Surrogate Endpoint (SUR): Probing pocket depth
Study 11966926 — Safety Biomarker (SAF): Reactive oxygen species
Study 16287352 — Surrogate Endpoint (SUR): Blood pressure
Study 2148357 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29931409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12943873 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 12943873 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12943873 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8763975 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 8763975 — Surrogate Endpoint (SUR): Blood pressure
Study 25725183 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 11727359 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 11727359 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 11727359 — Surrogate Endpoint (SUR): Blood pressure
Study 19185649 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11206241 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 7702336 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 7702336 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 21038947 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 11205485 — Surrogate Endpoint (SUR): Serum testosterone
Study 9755359 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 25722291 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 24049441 — Surrogate Endpoint (SUR): Forced vital capacity
Study 20872150 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 1405327 — Surrogate Endpoint (SUR): Blood pressure
Study 30570511 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 27196032 — Safety Biomarker (SAF): Reactive oxygen species
Study 1688983 — Surrogate Endpoint (SUR): Blood pressure
Study 1688983 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28070653 — Surrogate Endpoint (SUR): Blood pressure
Study 21992003 — Surrogate Endpoint (SUR): Blood pressure
Study 3311661 — Surrogate Endpoint (SUR): Blood pressure
Study 31738117 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 18651540 — Surrogate Endpoint (SUR): Bone mineral density
Study 9031453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25825948 — Surrogate Endpoint (SUR): Bone mineral density
Study 23492248 — Surrogate Endpoint (SUR): Blood pressure
Study 19608831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 11448901 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 2679035 — Surrogate Endpoint (SUR): Blood pressure
Study 19726772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19726772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19726772 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2740067 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study 25359409 — Surrogate Endpoint (SUR): Blood pressure
Study 25359409 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 17180485 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17180485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17180485 — Surrogate Endpoint (SUR): Blood pressure
Study 17180485 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 17180485 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 19646017 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 18257356 — Surrogate Endpoint (SUR): Blood pressure
Study 23327695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23327695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23327695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23327695 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 23327695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 23327695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23014487 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 205828 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 19720635 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27118470 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 27118470 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 27118470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26255172 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 7946102 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25403587 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 23234805 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study 21813840 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16673379 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 15112170 — Surrogate Endpoint (SUR): Serum creatinine
Study 1404350 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26700096 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 20582542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20582542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 20582542 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 20582542 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 10366800 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 10366800 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study 10366800 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 1928212 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 23074206 — Predictive Biomarker (PRD): DDIT4 mRNA
Genes: DDIT4; REDD1; RTP801
Study 7488479 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 19711440 — Surrogate Endpoint (SUR): Blood pressure
Study 11243303 — Surrogate Endpoint (SUR): Blood pressure
Study 8021901 — Surrogate Endpoint (SUR): Blood pressure
Study 7006616 — Surrogate Endpoint (SUR): Serum calcium
Study 30882927 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 26070127 — Safety Biomarker (SAF): Hyaluronic acid
Study 26181252 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26181252 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26181252 — Surrogate Endpoint (SUR): Pathological complete response
Study 26181252 — Predictive Biomarker (PRD): Hormone receptor
Study 19420195 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 15253732 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15253732 — Surrogate Endpoint (SUR): Blood pressure
Study 15253732 — Surrogate Endpoint (SUR): Serum creatinine
Study 15253732 — Surrogate Endpoint (SUR): Serum potassium
Study 9305229 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 25495543 — Surrogate Endpoint (SUR): Blood pressure
Study 22795063 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 12520156 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 23682797 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21950736 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 2654321 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8004613 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29980233 — Surrogate Endpoint (SUR): Blood pressure
Study 21110088 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 12660669 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 12660669 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12660669 — Surrogate Endpoint (SUR): Serum creatinine
Study 12660669 — Surrogate Endpoint (SUR): Blood pressure
Study 12660669 — Surrogate Endpoint (SUR): Serum uric acid
Study 10735416 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 10735416 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27394134 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 20686425 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 11824857 — Surrogate Endpoint (SUR): Blood pressure
Study 31827356 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 25345354 — Surrogate Endpoint (SUR): Blood pressure
Study 1279299 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1279299 — Surrogate Endpoint (SUR): Blood pressure
Study 24293660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15966884 — Surrogate Endpoint (SUR): Probing pocket depth
Study 8607399 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 28993070 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 27287084 — Surrogate Endpoint (SUR): Bone mineral density
Study 18818160 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7048877 — Surrogate Endpoint (SUR): Blood pressure
Study 26017328 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 21350839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 12479763 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12479763 — Surrogate Endpoint (SUR): Blood pressure
Study 9489629 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8106695 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28300357 — Surrogate Endpoint (SUR): Blood pressure
Study 25877139 — Surrogate Endpoint (SUR): Blood pressure
Study 23485720 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 28931404 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 17701167 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23816039 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study 23816039 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23816039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23816039 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16214632 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 15474696 — Surrogate Endpoint (SUR): Blood pressure
Study 8061901 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 3421209 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22212275 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22212275 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 22212275 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8733683 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 8733683 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 8733683 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 24368307 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study 18974967 — Surrogate Endpoint (SUR): Blood pressure
Study 11577993 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 11577993 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 11577993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22447494 — Safety Biomarker (SAF): IL16
Genes: LCF; IL-16; prIL-16; HsT19289; FLJ42735; FLJ16806
Study 20470337 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 15919488 — Surrogate Endpoint (SUR): Blood pressure
Study 6475654 — Surrogate Endpoint (SUR): Serum potassium
Study 30392345 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 26337132 — Surrogate Endpoint (SUR): Serum creatinine
Study 22425474 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 22425474 — Safety Biomarker (SAF): BDNF
Study 20379679 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 1332463 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1332463 — Surrogate Endpoint (SUR): Blood pressure
Study 21380565 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 20212256 — Predictive Biomarker (PRD): Hormone receptor
Study 8941005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1338084 — Surrogate Endpoint (SUR): Blood pressure
Study 31044234 — Surrogate Endpoint (SUR): Blood pressure
Study 21999631 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8453797 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8453797 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26321012 — Surrogate Endpoint (SUR): Blood pressure
Study 16636857 — Surrogate Endpoint (SUR): Serum testosterone
Study 3167937 — Surrogate Endpoint (SUR): Blood pressure
Study 28199799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19373128 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 2356812 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30298469 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 30298469 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30298469 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 31720788 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 26574567 — Surrogate Endpoint (SUR): Blood pressure
Study 7815572 — Surrogate Endpoint (SUR): Serum creatinine
Study 31085679 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31085679 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 25398689 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22260858 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study 15375787 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15375787 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9733054 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9733054 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22041483 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 14660727 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 12013487 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12013487 — Surrogate Endpoint (SUR): Blood pressure
Study 24227120 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24227120 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22804943 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 19789153 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9197291 — Surrogate Endpoint (SUR): Serum creatinine
Study 7951525 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 10472212 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 10472212 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 10472212 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 1651894 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 1651894 — Surrogate Endpoint (SUR): Blood pressure
Study 25913664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24091694 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24091694 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 11986563 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 12873166 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 7664720 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26580831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26580831 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21818510 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study 9287262 — Surrogate Endpoint (SUR): Blood pressure
Study 8346578 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 30679318 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30679318 — Predictive Biomarker (PRD): Hormone receptor
Study 27646064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 20411996 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 20411996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20411996 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20411996 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 18182939 — Surrogate Endpoint (SUR): Blood pressure
Study 15806847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 25236838 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 14752209 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30932776 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31740871 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 31249252 — Surrogate Endpoint (SUR): Blood pressure
Study 21094811 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 15625770 — Surrogate Endpoint (SUR): Blood pressure
Study 15625770 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15625770 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10822211 — Surrogate Endpoint (SUR): Blood pressure
Study 10822211 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10822211 — Surrogate Endpoint (SUR): Serum potassium
Study 31929250 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26424102 — Surrogate Endpoint (SUR): Blood pressure
Study 15655272 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15251771 — Surrogate Endpoint (SUR): Blood pressure
Study 15251771 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15251771 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8350218 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 10204597 — Surrogate Endpoint (SUR): Blood pressure
Study 8833935 — Surrogate Endpoint (SUR): Serum creatinine
Study 8833935 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 28181675 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 12929472 — Surrogate Endpoint (SUR): Blood pressure
Study 12929472 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27904554 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP